Data is not available at this time.
Sekisui Kasei Co., Ltd. operates as a specialized chemical manufacturer, focusing on high-performance plastic products across two core segments: Human Life and Industry. The Human Life segment caters to agricultural, food packaging, and construction applications with products like ESLEN beads and INTERFOAM, while the Industry segment serves automotive, industrial packaging, and healthcare markets with advanced materials such as PIOCELAN and TECHPOLYMER. The company’s diversified product portfolio positions it as a key supplier in niche markets, leveraging Japan’s advanced manufacturing ecosystem while expanding globally. Sekisui Kasei differentiates itself through proprietary foam and molded plastic technologies, addressing demand for lightweight, durable, and sustainable materials. Its market position is reinforced by long-standing client relationships in automotive and industrial supply chains, though it faces competition from global chemical giants and regional players. The 2020 rebranding to Sekisui Kasei reflects a strategic shift toward higher-value solutions, aligning with trends in eco-friendly materials and precision manufacturing.
For FY2024, Sekisui Kasei reported revenue of ¥130.3 billion, with net income of ¥1.1 billion, translating to a diluted EPS of ¥23.9. Operating cash flow stood at ¥7.4 billion, though capital expenditures of ¥3.8 billion indicate ongoing investments in production capacity. The modest net margin of 0.8% suggests cost pressures or competitive pricing dynamics in its segments.
The company’s earnings power is constrained by thin margins, with operating cash flow covering only a portion of its ¥37.9 billion total debt. ROIC metrics are unavailable, but the low beta (0.255) implies stable but subdued earnings volatility relative to the market.
Sekisui Kasei holds ¥10.9 billion in cash against ¥37.9 billion total debt, indicating moderate leverage. The debt-to-equity ratio is unclear, but liquidity appears manageable given consistent operating cash flow generation.
Growth trends are not explicitly detailed, but the dividend payout of ¥13 per share reflects a conservative policy, prioritizing reinvestment over shareholder returns. Global expansion and material innovation could drive future top-line growth.
With a market cap of ¥14.5 billion, the stock trades at a P/E of ~13.4x (based on diluted EPS), suggesting modest market expectations. The low beta aligns with its defensive positioning in specialty chemicals.
Sekisui Kasei’s strengths lie in its technological expertise and diversified industrial applications. Challenges include margin compression and debt management. The outlook hinges on scaling high-value products and geographic diversification, particularly in automotive and healthcare materials.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |